172 related articles for article (PubMed ID: 15547674)
1. Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease.
Falcone C; Campo I; Emanuele E; Buzzi MP; Zorzetto M; Sbarsi I; Cuccia M
Int J Mol Med; 2004 Dec; 14(6):1061-4. PubMed ID: 15547674
[TBL] [Abstract][Full Text] [Related]
2. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes.
Kirbis J; Milutinović A; Steblovnik K; Teran N; Terzić R; Zorc M
Coll Antropol; 2004 Dec; 28(2):611-6. PubMed ID: 15666591
[TBL] [Abstract][Full Text] [Related]
3. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus.
Peng WH; Lu L; Wang LJ; Yan XX; Chen QJ; Zhang Q; Zhang RY; Shen WF
Arch Med Res; 2009 Jul; 40(5):393-8. PubMed ID: 19766904
[TBL] [Abstract][Full Text] [Related]
4. -374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis.
Falcone C; Campo I; Emanuele E; Buzzi MP; Geroldi D; Belvito C; Zorzetto M; Sbarsi I; Cuccia M
Clin Chim Acta; 2005 Apr; 354(1-2):111-6. PubMed ID: 15748606
[TBL] [Abstract][Full Text] [Related]
5. The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease.
Falcone C; Geroldi D; Buzzi MP; Emanuele E; Yilmaz Y; Fontana JM; Vignali L; Boiocchi C; Sbarsi I; Cuccia M
Arch Med Res; 2008 Apr; 39(3):320-5. PubMed ID: 18279705
[TBL] [Abstract][Full Text] [Related]
6. [Association of C1019T polymorphism in the connexin 37 gene and coronary artery disease in Chinese Han population].
Han YL; Xi SY; Zhang XL; Yan CH; Yang Y; Kang J
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):100-4. PubMed ID: 17418016
[TBL] [Abstract][Full Text] [Related]
7. The association between the -374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studies.
Engelen L; Ferreira I; Gaens KH; Henry RM; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; van Greevenbroek MM; van der Kallen CJ; Blaak EE; Feskens EJ; Ten Cate H; Stehouwer CD; Schalkwijk CG
J Hypertens; 2010 Feb; 28(2):285-93. PubMed ID: 20051912
[TBL] [Abstract][Full Text] [Related]
8. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
Däbritz J; Friedrichs F; Weinhage T; Hampe J; Kucharzik T; Lügering A; Broeckel U; Schreiber S; Spieker T; Stoll M; Foell D
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G823-32. PubMed ID: 21311028
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
10. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
11. Association of estrogen receptor alpha gene polymorphism with the presence of coronary artery disease documented by coronary angiography.
Boroumand M; Ghaedi M; Mohammadtaghvaei N; Pourgholi L; Anvari MS; Davoodi G; Amirzadegan A; Saadat S; Sheikhfathollahi M; Goodarzynejad H
Clin Biochem; 2009 Jun; 42(9):835-9. PubMed ID: 19318036
[TBL] [Abstract][Full Text] [Related]
12. The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease.
Rhee EJ; Oh KW; Lee WY; Kim SY; Jung CH; Kim BJ; Sung KC; Kim BS; Kang JH; Lee MH; Kim SW; Park JR
Metabolism; 2006 Oct; 55(10):1344-51. PubMed ID: 16979405
[TBL] [Abstract][Full Text] [Related]
13. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.
Vogiatzi K; Voudris V; Apostolakis S; Kochiadakis GE; Thomopoulou S; Zaravinos A; Spandidos DA
Thromb Res; 2009 May; 124(1):84-9. PubMed ID: 19201454
[TBL] [Abstract][Full Text] [Related]
14. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.
Apostolakis S; Baritaki S; Kochiadakis GE; Igoumenidis NE; Panutsopulos D; Spandidos DA
Thromb Res; 2007; 119(1):63-71. PubMed ID: 16480760
[TBL] [Abstract][Full Text] [Related]
15. Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls.
Jaramillo PC; Muñoz M A; Lanas M C; Lanas Z F; Salazar LA
Clin Chim Acta; 2006 Sep; 371(1-2):102-6. PubMed ID: 16616056
[TBL] [Abstract][Full Text] [Related]
16. The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients.
Picheth G; Costantini CO; Pedrosa FO; Leme da Rocha Martinez T; Maltempi de Souza E
Clin Chem Lab Med; 2007; 45(10):1268-72. PubMed ID: 17924846
[TBL] [Abstract][Full Text] [Related]
17. Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease.
Kucukhuseyin O; Aydogan HY; Isbir CS; Isbir T
In Vivo; 2009; 23(6):949-54. PubMed ID: 20023238
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between Glu(298) asp polymorphism of endothelial nitric oxide synthase (eNOS) gene and coronary artery disease in Tamilian population.
Mathew J; Narayanan P; Sundaram R; Jayaraman B; Dutta TK; Raman SK; Chandrasekaran A
Indian Heart J; 2008; 60(3):223-7. PubMed ID: 19240311
[TBL] [Abstract][Full Text] [Related]
19. Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients.
Aydoğan HY; Küçükhüseyin O; Tekeli A; Isbir T
Genet Test Mol Biomarkers; 2012 Feb; 16(2):134-7. PubMed ID: 21861709
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
Balcerzyk A; Zak I; Krauze J
Arch Med Res; 2007 Jul; 38(5):545-50. PubMed ID: 17560461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
